Review
doi: 10.1038/sj.leu.2401361.
Role of MRP1 in multidrug resistance in acute myeloid leukemia
Affiliations
- PMID: 10214864
- DOI: 10.1038/sj.leu.2401361
Item in Clipboard
Review
Role of MRP1 in multidrug resistance in acute myeloid leukemia
Leukemia.
1999 Apr.
Abstract
The best characterized resistance mechanism in adult acute myeloid leukemia (AML) is the one mediated by the MDR1 gene which has been shown to be associated with poor outcome. However, alternative proteins such as the more recently recognized multidrug-associated protein (MRP1), may also contribute to the resistance to anthracyclines and etoposide in AML. Recently, the role of this protein was discussed and was unclear in AML. However, recent data concerning the functionality and the modulation of the activity of MRP1 may elucidate its role in comparison with other mechanisms of resistance. In this paper, we will review these recent data concerning the role of MRP1 in adult AML.
Similar articles
-
Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia.Blood. 1999 Aug 1;94(3):1046-56. Blood. 1999. PMID: 10419897
-
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.Blood. 1999 Aug 1;94(3):1086-99. Blood. 1999. PMID: 10419902 Clinical Trial.
-
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity.Blood. 2000 Jun 1;95(11):3514-9. Blood. 2000. PMID: 10828037
-
Novel mechanisms of drug resistance in leukemia.Leukemia. 2000 Mar;14(3):467-73. doi: 10.1038/sj.leu.2401694. Leukemia. 2000. PMID: 10720143 Review.
-
The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.Leuk Lymphoma. 1996 Feb;20(5-6):357-64. doi: 10.3109/10428199609052416. Leuk Lymphoma. 1996. PMID: 8833390 Review.
Cited by
-
Expression of MRP1 gene in acute leukemia.Sao Paulo Med J. 2008 May 1;126(3):172-9. doi: 10.1590/s1516-31802008000300007. Sao Paulo Med J. 2008. PMID: 18711657 Free PMC article.
-
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.Int J Hematol. 2013 Jun;97(6):703-16. doi: 10.1007/s12185-013-1365-1. Epub 2013 May 26. Int J Hematol. 2013. PMID: 23709007 Review.
-
Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia.Front Oncol. 2025 Jan 20;14:1532857. doi: 10.3389/fonc.2024.1532857. eCollection 2024. Front Oncol. 2025. PMID: 39902131 Free PMC article. Review.
-
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells.Oncotarget. 2016 Apr 26;7(17):23182-96. doi: 10.18632/oncotarget.8095. Oncotarget. 2016. PMID: 26992239 Free PMC article.
-
Antineoplastic Activity of Sodium Caseinate in a Cytarabine-Resistant Mouse Acute Myeloid Leukemia Cell Line.Nutrients. 2024 Sep 20;16(18):3190. doi: 10.3390/nu16183190. Nutrients. 2024. PMID: 39339789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
